PMV Pharmaceuticals Inc. Company Profile
NASDAQ: PMVPHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
PMV Pharmaceuticals at a glance
PMV Pharmaceuticals Inc. (NASDAQ: PMVP) is a Biotechnology company in the Healthcare sector headquartered in Princeton, NJ. PMV Pharmaceuticals is led by Dr. David H. Mack Ph.D. and employs about 54 people. The company's shares have traded publicly since 2020.
At a market capitalization of $113.3 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001699382, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does PMV Pharmaceuticals do?
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey.
Business description based on the company's public filings.
Company information
- Legal name
- PMV Pharmaceuticals Inc.
- Ticker
- NASDAQ: PMVP
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. David H. Mack Ph.D.
- Employees
- 54
- Headquarters
- 400 Alexander Park Drive, Princeton, NJ, United States
- Phone
- 609 642 6670
- Website
- pmvpharma.com
- IPO year
- 2020
- Market cap
- $113.27M
- SEC CIK
- 0001699382
- Latest annual report
- 10-K · Mar 6, 2026
Companies similar to PMV Pharmaceuticals
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| GNLXGenelux Corporation | 2.50 | -0.79% | $113.11M | vs PMVP |
| INOInovio Pharmaceuticals Inc. | 1.09 | -5.63% | $112.70M | vs PMVP |
| UNCYUnicycive Therapeutics Inc. | 4.07 | -2.63% | $111.49M | vs PMVP |
| RANIRani Therapeutics Holdings Inc. Class A | 0.792 | -2.48% | $111.29M | vs PMVP |
| VANIVivani Medical Inc. | 1.23 | -3.15% | $110.95M | vs PMVP |
| LENZLENZ Therapeutics Inc. | 3.53 | -2.49% | $110.91M | vs PMVP |
| COYACoya Therapeutics Inc. | 4.99 | +1.63% | $117.05M | vs PMVP |
| VTVTvTv Therapeutics Inc. Class A | 30.08 | -3.00% | $118.93M | vs PMVP |